ARANESP

NDC 55513-028 · Amgen, Inc

Generic namedarbepoetin alfa

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)DARBEPOETIN ALFA

Strength200 ug/.4mL

Pharmacologic classErythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]

Marketing categoryBLA

Packages

55513-028-01 — 1 BLISTER PACK in 1 PACKAGE (55513-028-01) / 1 SYRINGE in 1 BLISTER PACK / .4 mL in 1 SYRINGE

J0881 — Injection, darbepoetin alfa, 1 microgram (non-esrd use) Medicare Part B payment limit (ASP + 6%): $2.92

J0882 — Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) Medicare Part B payment limit (ASP + 6%): $2.92

FDA lists these products with the same active ingredient.

55513-002 — darbepoetin alfa, 55513-003 — darbepoetin alfa, 55513-004 — darbepoetin alfa, 55513-005 — darbepoetin alfa, 55513-006 — darbepoetin alfa, 55513-021 — darbepoetin alfa, 55513-023 — darbepoetin alfa, 55513-025 — darbepoetin alfa, 55513-027 — darbepoetin alfa, 55513-032 — darbepoetin alfa, 55513-057 — darbepoetin alfa, 55513-098 — darbepoetin alfa, 55513-111 — darbepoetin alfa

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.